338 related articles for article (PubMed ID: 29680803)
1. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults.
Sharafeldin N; Kawaguchi A; Sundaram A; Campbell S; Rudnisky C; Weis E; Tennant MTS; Damji KF
Br J Ophthalmol; 2018 Nov; 102(11):1485-1491. PubMed ID: 29680803
[TBL] [Abstract][Full Text] [Related]
2. Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada.
Boucher MC; Desroches G; Garcia-Salinas R; Kherani A; Maberley D; Olivier S; Oh M; Stockl F
Can J Ophthalmol; 2008 Dec; 43(6):658-68. PubMed ID: 19020631
[TBL] [Abstract][Full Text] [Related]
3. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore.
Nguyen HV; Tan GS; Tapp RJ; Mital S; Ting DS; Wong HT; Tan CS; Laude A; Tai ES; Tan NC; Finkelstein EA; Wong TY; Lamoureux EL
Ophthalmology; 2016 Dec; 123(12):2571-2580. PubMed ID: 27726962
[TBL] [Abstract][Full Text] [Related]
7. Urban diabetic retinopathy teleophthalmology screening: results and impact at the service corridor.
Boucher MC; El Yamani MEM
Can J Ophthalmol; 2019 Jun; 54(3):359-366. PubMed ID: 31109477
[TBL] [Abstract][Full Text] [Related]
8. Cost Analysis of Teleophthalmology Screening for Diabetic Retinopathy Using Teleophthalmology Billing Codes.
Ellis MP; Bacorn C; Luu KY; Lee SC; Tran S; Lillis C; Lim MC; Yiu G
Ophthalmic Surg Lasers Imaging Retina; 2020 May; 51(5):S26-S34. PubMed ID: 32484898
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration.
Kirkizlar E; Serban N; Sisson JA; Swann JL; Barnes CS; Williams MD
Ophthalmology; 2013 Dec; 120(12):2604-2610. PubMed ID: 24084501
[TBL] [Abstract][Full Text] [Related]
10. Diabetic retinopathy screening: a systematic review of the economic evidence.
Jones S; Edwards RT
Diabet Med; 2010 Mar; 27(3):249-56. PubMed ID: 20536486
[TBL] [Abstract][Full Text] [Related]
11. Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy.
Li Z; Wu C; Olayiwola JN; Hilaire DS; Huang JJ
Conn Med; 2012 Feb; 76(2):85-90. PubMed ID: 22670358
[TBL] [Abstract][Full Text] [Related]
12. Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.
Liu Y; Torres Diaz A; Benkert R
Curr Diab Rep; 2019 Aug; 19(9):74. PubMed ID: 31375932
[TBL] [Abstract][Full Text] [Related]
13. Teleophthalmology and Inequities in Diabetic Eye Disease at Safety Net Hospitals.
Snider MJE; Lee D; Chiang B; Gupta S; Khalifa Y; Maa AY
Telemed J E Health; 2022 Aug; 28(8):1134-1142. PubMed ID: 34978959
[No Abstract] [Full Text] [Related]
14. Tele-Ophthalmology for Age-Related Macular Degeneration and Diabetic Retinopathy Screening: A Systematic Review and Meta-Analysis.
Kawaguchi A; Sharafeldin N; Sundaram A; Campbell S; Tennant M; Rudnisky C; Weis E; Damji KF
Telemed J E Health; 2018 Apr; 24(4):301-308. PubMed ID: 28783458
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
16. Should We Add Screening of Age-Related Macular Degeneration to Current Screening Programs for Diabetic Retinopathy?
Chew EY; Schachat AP
Ophthalmology; 2015 Nov; 122(11):2155-6. PubMed ID: 26498078
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China.
Li R; Yang Z; Zhang Y; Bai W; Du Y; Sun R; Tang J; Wang N; Liu H
Lancet Reg Health West Pac; 2022 Jun; 23():100435. PubMed ID: 35355615
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of telemedicine to evaluate diabetic retinopathy in a prison population.
Aoki N; Dunn K; Fukui T; Beck JR; Schull WJ; Li HK
Diabetes Care; 2004 May; 27(5):1095-101. PubMed ID: 15111527
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness and diagnostic accuracy of telemedicine in macular disease and diabetic retinopathy: A systematic review and meta-analysis.
Ullah W; Pathan SK; Panchal A; Anandan S; Saleem K; Sattar Y; Ahmad E; Mukhtar M; Nawaz H
Medicine (Baltimore); 2020 Jun; 99(25):e20306. PubMed ID: 32569163
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities.
Pasquel FJ; Hendrick AM; Ryan M; Cason E; Ali MK; Narayan KM
J Diabetes Sci Technol; 2015 Dec; 10(2):301-7. PubMed ID: 26719134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
